Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in FLNA — Filana Therapeutics, Inc.

CIK 1692234 Seattle, WA
Back to FLNA Full portfolio

Position in FLNA

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$2,856
-$9,514 QoQ
Shares Held
2,400
-67.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 84 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FLNA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. FLNA ranks #296 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in FLNA

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,856 2,400
2026-03-31 $12,370 7,320
2025-12-31 $16,103 8,133
2025-09-30 $23,667 8,133
2025-06-30 $9,819 5,425
2025-03-31 $36,951 24,634
2024-12-31 $52,439 22,220
2024-09-30 $10,889 370
2024-06-30 $3,346 271
2024-03-31 $5,498 271
2023-12-31 $6,100 271
2023-09-30 $4,542 273
2023-06-30 $4,609 188
2022-12-31 $215,494 7,295
2022-09-30 $305,076 7,295
2022-06-30 $205,135 7,295
2022-03-31 $270,936 7,295
2021-12-31 $318,791 7,295
2021-09-30 $462,309 7,447
2021-06-30 $7,172,345 83,946
2021-03-31 $1,481,866 32,967